Net Loss per Share (Tables)

3 Months Ended

Mar. 31, 2026

Shares Not Included in Computation of Diluted Net Loss Per Share

The following shares were not considered in the computation of diluted net loss per share because their effect was anti-dilutive (in thousands):


	Three Months Ended March 31,
	2026	2025
Shares issuable under the Equity Incentive Plan and ESPP(1)	14,983	13,800
Warrants(2)	424	424
Total potentially dilutive securities	15,407	14,224

(1) Included anti-dilutive potential common shares from ESPP of 509,446 and 386,635 for the three months ended March 31, 2026 and 2025, respectively (actual shares).

(2) Pertains to the warrants issued in connection with the Innovatus Loan. For additional information, see Note 11, “Debt.”